「Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality.」 PMID:27329021 https://www.ncbi.nlm.nih.gov/pubmed/27329021 PECO P : メトホルミンが処方されている2型糖尿病患者(スウェーデン、527…
